Allosteric inhibitors of hepatitis C polymerase: Discovery of potent and orally bioavailable carbon-linked dihydropyrones

被引：36

作者：

Li, Hui ^{[1
]}

Linton, Angelica ^{[1
]}

Tatlock, John ^{[1
]}

Gonzalez, Javier ^{[1
]}

Borchardt, Allen ^{[1
]}

Abreo, Mel ^{[1
]}

Jewell, Tanya ^{[1
]}

Patel, Leena ^{[1
]}

Drowns, Matthew ^{[1
]}

Ludlum, Sarah ^{[1
]}

Goble, Mike ^{[1
]}

Yang, Michele ^{[1
]}

Blazel, Julie ^{[1
]}

Rahavendran, Ravi ^{[1
]}

Skor, Heather ^{[1
]}

Shi, Stephanie ^{[1
]}

Lewis, Cristina ^{[1
]}

Fuhrman, Shella ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, La Jolla Labs, San Diego, CA 92121 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 17期

关键词：

D O I：

10.1021/jm0704447

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery and optimization of a novel class of carbon-linked dihydropyrones as allosteric HCV NS5B polymerase inhibitors are presented. Replacement of the sulfur linker atom with carbon reduced compound acidity and greatly increased cell permeation. Further structure-activity relationship (SAR) studies led to the identification of compounds, exemplified by 23 and 24, with significantly improved antiviral activities in the cell-based replicon assay and favorable pharmacokinetic profiles.

引用

页码：3969 / 3972

页数：4

共 50 条

[21] Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2
Nguyen, Minh H.
Atasoylu, Onur
Wu, Liangxing
Kapilashrami, Kanishk
Pusey, Michelle
Gallagher, Karen
Lai, Cheng-Tsung
Zhao, Peng
Barbosa, Joseph
Liu, Kai
He, Chunhong
Zhang, Colin
Styduhar, Evan D.
Witten, Michael R.
Chen, Yaoyu
Lin, Luping
Yang, Yan-ou
Covington, Maryanne
Diamond, Sharon
Yeleswaram, Swamy
Yao, Wenqing
ACS MEDICINAL CHEMISTRY LETTERS, 2022, : 1159 - 1164
[22] Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase γ Inhibitors
Leahy, James W.
Buhr, Chris A.
Johnson, Henry W. B.
Kim, Byung Gyu
Baik, TaeGon
Cannoy, Jonah
Forsyth, Timothy P.
Jeong, Joon Won
Lee, Matthew S.
Ma, Sunghoon
Noson, Kevin
Wang, Longcheng
Williams, Matthew
Nuss, John M.
Brooks, Eric
Foster, Paul
Goon, Leanne
Heald, Nathan
Holst, Charles
Jaeger, Christopher
Lam, Scott
Lougheed, Julie
Lam Nguyen
Plonowski, Arthur
Song, Joanne
Stout, Thomas
Wu, Xiang
Yakes, Michael F.
Yu, Peiwen
Zhang, Wentao
Lamb, Peter
Raeber, Olivia
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5467 - 5482
[23] Discovery of potent, selective, orally bioavailable Stearoyl-CoA desaturase 1 inhibitors
Liu, Gang
Lynch, John K.
Freeman, Jennifer
Liu, Bo
Xin, Zhili
Zhao, Hongyu
Serby, Michael D.
Kym, Philip R.
Suhar, Tom S.
Smith, Harriet T.
Cao, Ning
Yang, Ruojing
Janis, Rich S.
Krauser, Joel A.
Cepa, Steven P.
Beno, David W. A.
Sham, Hing L.
Collins, Christine A.
Surowy, Teresa K.
Camp, Heidi S.
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (13) : 3086 - 3100
[24] Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
Wang, Yonghui
Cai, Wei
Cheng, Yaobang
Yang, Ting
Liu, Qian
Zhang, Guifeng
Meng, Qinghua
Han, Fangbin
Huang, Yafei
Zhou, Ling
Xiang, Zhijun
Zhao, Yong-Gang
Xu, Yan
Cheng, Ziqiang
Lu, Sijie
Wu, Qianqian
Xiang, Jia-Ning
Elliott, John D.
Leung, Stewart
Ren, Feng
Lin, Xichen
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07): : 787 - 792
[25] Discovery of potent, highly selective, and orally bioavailable factor XIa inhibitors for anticoagulant therapy
Zhang, Yajing
Huang, Rong
Hu, Xueqin
Zheng, Nan
Geng, Lei
Yin, Zequn
Duan, Yajun
Wang, Qin
Liao, Chenzhong
Yang, Xiaoxiao
Xie, Zhouling
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289
[26] Discovery of potent, selective and orally bioavailable phenylailanine based dipeptidyl peptioase IV inhibitors
Xu, JY
Wei, L
Mathvink, R
He, JF
Park, YJ
He, HB
Leiting, B
Lyons, KA
Marsilio, F
Patel, RA
Wu, JK
Thornberry, NA
Weber, AE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U145 - U145
[27] Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors
Chan, Shingpan
Zhang, Yunong
Wang, Jie
Yu, Qiuchun
Peng, Xia
Zou, Jian
Zhou, Licheng
Tan, Li
Duan, Yunxin
Zhou, Yang
Hur, Hoon
Ai, Jing
Wang, Zhen
Ren, Xiaomei
Zhang, Zhang
Ding, Ke
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (22) : 15374 - 15390
[28] Discovery and optimization of orally bioavailable, selective and potent ATP-independent Akt inhibitors
Chan, Thomas C. K.
Ashwell, Mark A.
Lapierre, Jean-Marc
Brassard, Christopher
Bull, Cathy
Cornell-Kennon, Susan
Eathiraj, Sudharshan
France, Dennis S.
Hill, Jason
Koerner, Steffi
Kelleher, Eoin
Kizer, Darin
Liu, Yanbin
Link, Jeff
Makhija, Sapna
Moussa, Magdi
Namdev, Nivedita
Nicewonger, Robert
Uppalapati, Uma
Palma, Rocio
Szwaya, Jeff
Tandon, Manish
Vensel, David
Volak, Laurie
Volckova, Erika
Westland, Neil
Wu, Hui
Yang, Rui-Yang
CANCER RESEARCH, 2012, 72
[29] Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease
Clarke, Michael O.
Chen, Xiaowu
Cho, Aesop
Delaney, William E.
Doerffler, Edward
Fardis, Maria
Ji, Mingzhe
Mertzman, Michael
Pakdaman, Rowchanak
Pyun, Hyun-Jun
Rowe, Tanisha
Yang, Cheng Y.
Sheng, X. Christopher
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3568 - 3572
[30] Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity
Leger, Paul R.
Hu, Dennis X.
Biannic, Berenger
Bui, Minna
Han, Xinping
Karbarz, Emily
Maung, Jack
Okano, Akinori
Osipov, Maksim
Shibuya, Grant M.
Young, Kyle
Higgs, Christopher
Abraham, Betty
Bradford, Delia
Cho, Cynthia
Colas, Christophe
Jacobson, Scott
Ohol, Yamini M.
Pookot, Deepa
Rana, Payal
Sanchez, Jerick
Shah, Niket
Sun, Michael
Wong, Steve
Brockstedt, Dirk G.
Kassner, Paul D.
Schwarz, Jacob B.
Wustrow, David J.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (10) : 5398 - 5420

← 1 2 3 4 5 →